Meysam Ganjibakhsh1, Fereshteh Mehraein2, Morteza Koruji1,3, Zahra Bashiri1,3. 1. Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. 2. Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. femehra@yahoo.com. 3. Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract
PURPOSE: The generation of germ cells from mesenchymal stromal cells (MSCs) provides a valuable in vitro platform for infertility modeling. The establishment of these cells is a new approach for assisted reproductive technology (ART) to help infertile patients who lack functional gametes. METHODS: Human adipose-derived MSCs were isolated and then characterized for multipotency by flow cytometry, differentiation capacity, and cytogenetic assays. These cells were used in a male germ cell differentiation study. The expression of male germ cell markers was evaluated at day 21 of differentiation using an immunofluorescence assay, flow cytometry, and RT-qPCR. Undifferentiated MSCs were used for transplantation in busulfan-induced azoospermic mice. RESULTS: In this study, MSCs were successfully isolated from human adipose tissues which were positive for cell markers such as CD90, CD105, CD73, and CD29 but negative for CD34 and CD45. The results of flow cytometry, immunocytochemistry, and RT-qPCR analysis at day 21 of differentiation showed that the undifferentiated adipose-derived MSCs are able to differentiate into male germ cells. Additionally, transplantation of undifferentiated MSCs in busulfan-induced azoospermic mice caused spermatogenesis recovery in the majority of seminiferous tubules. CONCLUSION: In this study, we showed that differentiation of human adipose-derived MSCs into male germ cells is a useful tool for in vitro study of human germ cell development. Our results demonstrated that cell therapy with adipose-derived MSCs could help the repair of pathological changes in testicular seminiferous tubules. Therefore, it may have a clinical application for the treatment of azoospermia in infertile patients.
PURPOSE: The generation of germ cells from mesenchymal stromal cells (MSCs) provides a valuable in vitro platform for infertility modeling. The establishment of these cells is a new approach for assisted reproductive technology (ART) to help infertile patients who lack functional gametes. METHODS: Human adipose-derived MSCs were isolated and then characterized for multipotency by flow cytometry, differentiation capacity, and cytogenetic assays. These cells were used in a male germ cell differentiation study. The expression of male germ cell markers was evaluated at day 21 of differentiation using an immunofluorescence assay, flow cytometry, and RT-qPCR. Undifferentiated MSCs were used for transplantation in busulfan-induced azoospermic mice. RESULTS: In this study, MSCs were successfully isolated from human adipose tissues which were positive for cell markers such as CD90, CD105, CD73, and CD29 but negative for CD34 and CD45. The results of flow cytometry, immunocytochemistry, and RT-qPCR analysis at day 21 of differentiation showed that the undifferentiated adipose-derived MSCs are able to differentiate into male germ cells. Additionally, transplantation of undifferentiated MSCs in busulfan-induced azoospermic mice caused spermatogenesis recovery in the majority of seminiferous tubules. CONCLUSION: In this study, we showed that differentiation of human adipose-derived MSCs into male germ cells is a useful tool for in vitro study of human germ cell development. Our results demonstrated that cell therapy with adipose-derived MSCs could help the repair of pathological changes in testicular seminiferous tubules. Therefore, it may have a clinical application for the treatment of azoospermia in infertile patients.
Authors: Jason K Cooper; Greg Sykes; Steve King; Karin Cottrill; Natalia V Ivanova; Robert Hanner; Pranvera Ikonomi Journal: In Vitro Cell Dev Biol Anim Date: 2007-10-13 Impact factor: 2.416
Authors: Eelco Fennema; Nicolas Rivron; Jeroen Rouwkema; Clemens van Blitterswijk; Jan de Boer Journal: Trends Biotechnol Date: 2013-01-18 Impact factor: 19.536
Authors: Cyril Ramathal; Jens Durruthy-Durruthy; Meena Sukhwani; Joy E Arakaki; Paul J Turek; Kyle E Orwig; Renee A Reijo Pera Journal: Cell Rep Date: 2014-05-01 Impact factor: 9.423
Authors: Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring Journal: Cell Stem Cell Date: 2011-01-07 Impact factor: 24.633
Authors: Charles A Easley; Bart T Phillips; Megan M McGuire; Jennifer M Barringer; Hanna Valli; Brian P Hermann; Calvin R Simerly; Aleksander Rajkovic; Toshio Miki; Kyle E Orwig; Gerald P Schatten Journal: Cell Rep Date: 2012-08-23 Impact factor: 9.423